Staniszewska, M.; Fragoso Costa, P.; Eiber, M.; Klose, J.M.; Wosniack, J.; Reis, H.; Szarvas, T.; Hadaschik, B.; Lückerath, K.; Herrmann, K.;
et al. Enzalutamide Enhances PSMA Expression of PSMA-Low Prostate Cancer. Int. J. Mol. Sci. 2021, 22, 7431.
https://doi.org/10.3390/ijms22147431
AMA Style
Staniszewska M, Fragoso Costa P, Eiber M, Klose JM, Wosniack J, Reis H, Szarvas T, Hadaschik B, Lückerath K, Herrmann K,
et al. Enzalutamide Enhances PSMA Expression of PSMA-Low Prostate Cancer. International Journal of Molecular Sciences. 2021; 22(14):7431.
https://doi.org/10.3390/ijms22147431
Chicago/Turabian Style
Staniszewska, Magdalena, Pedro Fragoso Costa, Matthias Eiber, Jasmin M. Klose, Jasmin Wosniack, Henning Reis, Tibor Szarvas, Boris Hadaschik, Katharina Lückerath, Ken Herrmann,
and et al. 2021. "Enzalutamide Enhances PSMA Expression of PSMA-Low Prostate Cancer" International Journal of Molecular Sciences 22, no. 14: 7431.
https://doi.org/10.3390/ijms22147431
APA Style
Staniszewska, M., Fragoso Costa, P., Eiber, M., Klose, J. M., Wosniack, J., Reis, H., Szarvas, T., Hadaschik, B., Lückerath, K., Herrmann, K., Fendler, W. P., & Iking, J.
(2021). Enzalutamide Enhances PSMA Expression of PSMA-Low Prostate Cancer. International Journal of Molecular Sciences, 22(14), 7431.
https://doi.org/10.3390/ijms22147431